PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Apr-2026 SonoNeu exits stealth as key part of US Government-funded research program worth up to $41.3m to advance sonogenetics into clinic SonoNeu
07-Apr-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Apr-2026 ABION Presents Preclinical Data at AACR Showing IFN-β Antibody Fusion ABN202 Outperforms TROP2-Targeting ADCs Businesswire
07-Apr-2026 AlzeCure Pharma to Present at Redeye Healthcare Day on April 14 ACCESS Newswire
07-Apr-2026 Theis Kipling New CEO for Biovica ACCESS Newswire
07-Apr-2026 Dosell AB Awarded Contract with Region Jönköping County and its Municipalities ACCESS Newswire
07-Apr-2026 BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries ACCESS Newswire
06-Apr-2026 Fluor Signs Contract With X-Energy for Advanced Nuclear Project in Texas Businesswire
06-Apr-2026 Vertex to Announce First Quarter 2026 Financial Results on May 4th Businesswire
06-Apr-2026 Section 232 Pharmaceutical Tariffs - Biocom Statement Businesswire
06-Apr-2026 Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026 ACCESS Newswire
06-Apr-2026 NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study ACCESS Newswire
06-Apr-2026 RARE FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 Businesswire
06-Apr-2026 Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update ACCESS Newswire
06-Apr-2026 Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine Businesswire
06-Apr-2026 Fidus Systems Appoints Stan Lequin Chief Executive Officer Businesswire
06-Apr-2026 Frazier Life Sciences Appoints Christian Schade as Senior Advisor Businesswire
06-Apr-2026 ImmunityBio Addresses FDA Correspondence and Reaffirms Commitment to Advertising Compliance Businesswire
06-Apr-2026 GE HealthCare to announce first quarter 2026 results on April 29, 2026 Businesswire
06-Apr-2026 Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting Businesswire